AZNCF - AstraZeneca PLC (AZN) Presents at ESMO Investor Science Broker Conference - (Transcript)
AstraZeneca PLC (AZN) ESMO Investor Science Conference Call September 20, 2021, 03:00 ET Company Participants Chris Sheldon - IR Susan Galbraith - EVP, Oncology Research & Development Sara Hurvitz - Senior Investigator David Fredrickson - Executive Vice-President, Oncology Business Unit Sunil Verma - VP, Global Clinical Head, Breast Cancer & Head of Breast Cancer Research Strategy Cristian Massacesi - Chief Medical Officer & Oncology Chief Development Officer Conference Call Participants Emmanuel Papadakis - Deutsche Bank Simon Baker - Redburn Andrew Baum - Citigroup Jo Walton - Crédit Suisse Seamus Fernandez - Guggenheim Securities Luisa Hector - Berenberg Richard Parkes - Exane BNP Paribas Peter Welford - Jefferies Stephen Scala - Cowen and Company Presentation Operator Welcome, ladies and gentlemen, to AstraZeneca's Investor conference Call ESMO 2021. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement. The company intends to utilize the safe harbor provisions of
For further details see:
AstraZeneca PLC (AZN) Presents at ESMO Investor Science Broker Conference - (Transcript)